3rd Annual Pharma Pricing, Reimbursement & Market Access 2019


Pricing And Market Access (P&Ma) are key concerns for the Pharma industry as healthcare budgets remain to tighten and the value of advanced drugs, particularly in areas of high unmet need, becomes infinitely solider to assess. Pharma and payers are forceful to find a balance between budget management and patient access. Pricing has consistently been a pressure point.

Read »
Created by sonikashukla98 39 weeks 4 days ago – Made popular 39 weeks 3 days ago
Category: Health   Tags:

User login

EzySpot is a news/social bookmarking site.